CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for acquisition of approximately 15 percent equity shareholding of Biocon Biologics by Serum Institute Life Sciences
Thursday May 19, 2022, 11550 Hrs [IST]
Share this article
Read other Indian Government Press Release stories
Visit news Home Page for fresh content